Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells-Reference-Cited by-同舟云学术

Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells

Published:2018-09-20 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Juliá Estefanía Paula,Amante Analía,Pampena María Betina,Mordoh José,Levy Estrella Mariel

Funder

Consejo Nacional de Investigaciones Científicas y Técnicas

Agencia Nacional de Promoción Científica y Tecnológica

Merck KGaA

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference65 articles.

1. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype;Bauer;Cancer,2007

2. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes;Carey;Clin Cancer Res,2007

3. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007

4. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents;André;Ann Oncol,2012

5. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J Clin Invest,2011

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The basic biology of NK cells and its application in tumor immunotherapy;Frontiers in Immunology;2024-08-16

2. TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients;npj Imaging;2024-07-25

3. Unveiling the impact: A decade review on dihydropyrimidinones (DHPMs) to combat breast cancer;Journal of Molecular Structure;2024-07

4. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28

5. Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1;Cell Chemical Biology;2024-05